Zhicheng Lin - Publications

Affiliations: 
NEPRC Psychiatry Harvard Medical School, Boston, MA, United States 

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Hasbi A, Madras BK, Bergman J, Kohut S, Lin Z, Withey SL, George SR. Δ-Tetrahydrocannabinol Increases Dopamine D1-D2 Receptor Heteromer and Elicits Phenotypic Reprogramming in Adult Primate Striatal Neurons. Iscience. 23: 100794. PMID 31972514 DOI: 10.1016/J.Isci.2019.100794  0.438
2018 Canseco-Alba A, Schanz N, Sanabria B, Zhao J, Lin Z, Liu QR, Onaivi ES. Behavioral effects of psychostimulants in mutant mice with cell-type specific deletion of CB2 cannabinoid receptors in dopamine neurons. Behavioural Brain Research. PMID 30508607 DOI: 10.1016/j.bbr.2018.11.043  0.334
2017 Liu QR, Canseco-Alba A, Zhang HY, Tagliaferro P, Chung M, Dennis E, Sanabria B, Schanz N, Escosteguy-Neto JC, Ishiguro H, Lin Z, Sgro S, Leonard CM, Santos-Junior JG, Gardner EL, et al. Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference. Scientific Reports. 7: 17410. PMID 29234141 DOI: 10.1038/S41598-017-17796-Y  0.318
2016 Sheng Y, Filichia E, Shick E, Preston KL, Phillips KA, Cooperman L, Lin Z, Tesar P, Hoffer BJ, Luo Y. Lower Dopamine D2 Receptor Expression Levels in Human Dopaminergic Neurons Derived From Opioid-Dependent iPSCs. The American Journal of Psychiatry. 173: 429-431. PMID 27035534 DOI: 10.1176/Appi.Ajp.2015.15121545  0.323
2012 Zhao Y, Zhou Y, Xiong N, Lin Z. Identification of an intronic cis-acting element in the human dopamine transporter gene. Molecular Biology Reports. 39: 5393-9. PMID 22160470 DOI: 10.1007/s11033-011-1339-4  0.338
2011 Xiong N, Xiong J, Khare G, Chen C, Huang J, Zhao Y, Zhang Z, Qiao X, Feng Y, Reesaul H, Zhang Y, Sun S, Lin Z, Wang T. Edaravone guards dopamine neurons in a rotenone model for Parkinson's disease. Plos One. 6: e20677. PMID 21677777 DOI: 10.1371/journal.pone.0020677  0.302
2006 Madras BK, Fahey MA, Goulet M, Lin Z, Bendor J, Goodrich C, Meltzer PC, Elmaleh DR, Livni E, Bonab AA, Fischman AJ. Dopamine transporter (DAT) inhibitors alleviate specific parkinsonian deficits in monkeys: association with DAT occupancy in vivo. The Journal of Pharmacology and Experimental Therapeutics. 319: 570-85. PMID 16885433 DOI: 10.1124/Jpet.106.105312  0.501
2006 Madras BK, Xie Z, Lin Z, Jassen A, Panas H, Lynch L, Johnson R, Livni E, Spencer TJ, Bonab AA, Miller GM, Fischman AJ. Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. The Journal of Pharmacology and Experimental Therapeutics. 319: 561-9. PMID 16885432 DOI: 10.1124/Jpet.106.106583  0.477
2004 Dohi T, Kitayama S, Morioka N, Kumagai K, Mitsuhata C, Morita K, Kozai K, Lin Z, Uhl GR. Regulation of dopamine and MPP+ transport by catecholamine transporters. Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology. 24: 43-7. PMID 15164608  0.327
2003 Lin Z, Uhl GR. Human dopamine transporter gene variation: effects of protein coding variants V55A and V382A on expression and uptake activities. The Pharmacogenomics Journal. 3: 159-68. PMID 12815364 DOI: 10.1038/sj.tpj.6500169  0.374
2002 Itokawa M, Lin Z, Uhl GR. Dopamine efflux via wild-type and mutant dopamine transporters: alanine substitution for proline-572 enhances efflux and reduces dependence on extracellular dopamine, sodium and chloride concentrations. Brain Research. Molecular Brain Research. 108: 71-80. PMID 12480180 DOI: 10.1016/S0169-328X(02)00515-6  0.367
Show low-probability matches.